Zacks Investment Research on MSN
DXCM receives FDA clearance for Stelo OTC CGM system for children
DexCom DXCM received FDA clearance for its Stelo Glucose Biosensor System for use in children aged two years and older who do ...
The U.S. Food and Drug Administration (FDA) on Friday cleared Dexcom Inc.‘s DXCM Stelo Glucose Biosensor System for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results